Representing the developed world, the United States will maintain a 9.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$66.1 Million to the region's size and clout in the next 5 to 6 years. Over US$54.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Synthesized Oligonucleotides will reach a market size of US$78.9 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.8% over the next couple of years and add approximately US$394.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- ATDBio Ltd.
- Bio-Synthesis Inc.
- GE Healthcare Life Sciences
- GeneDesign, Inc.
- GenScript Biotech Corporation
- Integrated DNA Technologies (IDT), Inc.
- LGC Biosearch Technologies
- Merck KgaA
- Nitto Denko Avecia Inc.
- Thermo Fisher Scientific, Inc.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Oligonucleotide Synthesis Market Set for a Steady Growth
Oligonucleotide Synthesis Market by End-use: 2018
Oligonucleotide Synthesis Market Breakdown by Geographic Region: 2018
Global Competitor Market Shares
Oligonucleotide Synthesis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Demand for Oligonucleotide-based Drugs to Boost the Oligonucleotide Synthesis Market
Increased Pharma R&D to Spur the Market Growth
FDA-Approved Oligonucleotide-based Drugs Promise Huge Potential for Market Growth
Recent Approval of Exondys 51 and Nusinersen Aids in Treatment of Inherited Diseases
Oligonucleotide Drugs Aid Effective Treatment of Neurodegenerative Disorders
Inotersen – The Second FDA Approved Drug for Polyneuropathy, Following Onpattro
Market Outlook and Advancements in Antisense Drugs
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
US Oligonucleotide Synthesis Market Share (in %) by Company: 2019 & 2025
Market Facts & Figures
European Oligonucleotide Synthesis Market: Competitor Market Share Scenario (in %) for 2019 & 2025
REST OF EUROPE
REST OF ASIA-PACIFIC
Oligonucleotide Synthesis Market by Application: 2014-2025
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
GE HEALTHCARE LIFE SCIENCES
GENSCRIPT BIOTECH CORPORATION
INTEGRATED DNA TECHNOLOGIES (IDT), INC.
LGC BIOSEARCH TECHNOLOGIES
NITTO DENKO AVECIA INC.
THERMO FISHER SCIENTIFIC
V. CURATED RESEARCH
- ATDBIO LTD.
- BIO-SYNTHESIS INC.
- GE HEALTHCARE LIFE SCIENCES
- GENSCRIPT BIOTECH CORPORATION
- INTEGRATED DNA TECHNOLOGIES (IDT), INC.
- LGC BIOSEARCH TECHNOLOGIES
- MERCK KGAA
- NITTO DENKO AVECIA INC.